Fitch Rates Symphony CLO XVI, Ltd./LLC; Publishes New Issue Report
CHICAGO--(BUSINESS WIRE)-- Fitch Ratings assigns the following ratings to Symphony CLO XVI, Ltd./LLC:
--$256,000,000 class A notes 'AAAsf'; Outlook Stable.
Fitch does not rate the class B-1, B-2, C, D, E or F notes or the subordinated notes.
TRANSACTION SUMMARY
Symphony CLO XVI, Ltd. (the issuer) and Symphony CLO XVI LLC (the co-issuer) comprise an arbitrage cash flow collateralized loan obligation (CLO) that will be managed by Symphony Asset Management LLC (Symphony). Net proceeds from the issuance of the secured and subordinated notes will be used to purchase a portfolio of approximately $400 million of primarily senior secured leveraged loans. The CLO will have a five-year reinvestment period and a three-year noncall period.
KEY RATING DRIVERS
Sufficient Credit Enhancement: Credit enhancement (CE) of 36.0% for class A notes, in addition to excess spread, is sufficient to protect against portfolio default and recovery rate projections in a 'AAAsf' stress scenario. The degree of CE available to class A notes is in line with the average CE of recent CLO issuances.
'B' Asset Quality: The average credit quality of the indicative portfolio is 'B', which is comparable to recent CLOs. Issuers rated in the 'B' rating category denote a highly speculative credit quality; however, in Fitch Ratings' opinion, class A notes are unlikely to be affected by the foreseeable level of defaults. Class A notes are projected to be able to withstand default rates of up to 64.5%.
Strong Recovery Expectations: The indicative portfolio consists of 94.6% first lien senior secured loans. Approximately 87.0% of the indicative portfolio has either strong recovery prospects or a Fitch-assigned recovery rating of 'RR2' or higher, resulting in a base case recovery assumption of 75.4%. In determining the class A note ratings, Fitch stressed the indicative portfolio by assuming a higher portfolio concentration of assets with lower recovery prospects and further reduced recovery assumptions of higher rating stress assumptions. The analysis of class A notes assumed a 37.9% recovery rate in Fitch's 'AAAsf' scenario.
RATING SENSITIVITIES
Fitch evaluated the structure's sensitivity to the potential variability of key model assumptions, including decreases in recovery rates and increases in default rates or correlation. Fitch expects the class A notes to remain investment grade even under the most extreme sensitivity scenarios. Results under these sensitivity scenarios ranged between 'Asf' and 'AAAsf' for the class A notes.
Key Rating Drivers and Rating Sensitivities are further described in the accompanying new issue report, available by clicking the link above.
DUE DILIGENCE USAGE
No third party due diligence was provided or reviewed in relation to this rating action.
Click the link below for an analysis of the representations, warranties, and enforcement mechanisms available to investors in transaction documents for this transaction and how they compare to those of similar securities.
Additional information is available at www.fitchratings.com.
Sources of Information:
The sources of information used to assess these ratings were provided by the arranger (Merrill Lynch, Pierce, Fenner & Smith Incorporated) and the public domain.
Symphony CLO XVI, Ltd./LLC
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=867913
Applicable Criteria
Counterparty Criteria for Structured Finance and Covered Bonds (pub. 14 May 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=744158
Criteria for Interest Rate Stresses in Structured Finance Transactions and Covered Bonds (pub. 19 Dec 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=838868
Global Rating Criteria for Corporate CDOs (pub. 25 Jul 2014)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=753057
Global Structured Finance Rating Criteria (pub. 06 Jul 2015)
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=867952
Related Research
Symphony CLO XVI, Ltd./LLC - Appendix
https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=868577
Additional Disclosures
Dodd-Frank Rating Information Disclosure Form
https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=987974
Solicitation Status
https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=987974
Endorsement Policy
https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31
ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150715006431/en/
Fitch Ratings
Joseph Farfsing
Associate Director
+1-312-368-3346
Fitch
Ratings, Inc.
70 West Madison Street
Chicago, IL 60602
or
Secondary
Analyst
Robert Rhein
Director
+1-312-606-2314
or
Committee
Chairperson
Derek Miller
Senior Director
+1-312-368-2076
or
Media
Relations:
Sandro Scenga, New York, +1 212-908-0278
Email: [email protected]
Source: Fitch Ratings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eylsia Nicolas Continues Her Global Surge: New BookKard Release, Power Ace Radio Honors, and a Life Story Spanning Tennis Triumphs, Hollywood Turbulence, Academic Leadership, Patented Sound Technology
- Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
- New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Fitch RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share